By interfering with the autophagic flux and promoting apoptosis, heparanase inhibitors may enhance the sensitivity of glioblastoma cells to therapeutic agents, providing a promising approach for treatment strategies (Carolyn G and Renato V, 2022). The gene discussed is HPSE; the disease is glioblastoma.